National Toxicology Program

National Toxicology Program
https://ntp.niehs.nih.gov/go/28482

Abstract for GMM-07

ABSTRACT

Toxicology Studies of Allyl Bromide (CAS No. 106-95-6) in Genetically Modified (FVB Tg.AC Hemizygous) Mice and Carcinogenicity Studies of Allyl Bromide in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Dermal and Gavage Studies)

Chemical Formula: C3H5Br Molecular Weight: 120.99

Allyl bromide is primarily used as a starting material/chemical intermediate in organic synthesis and as an intermediate in the manufacture of polymers/resins, synthetic perfumes, pharmaceuticals, agricultural chemicals, and other allyl compounds. It has been described as an insecticidal fumigant used in crop protection. Male and female FVB/N and C57BL/6 mice received allyl bromide (greater than 99% pure) by gavage and dermal application, respectively, for 2 weeks, and FVB/N, C57BL/6, Tg.AC hemizygous, and p53 haploinsufficient mice received allyl bromide by gavage for 40 weeks. Genetic toxicology studies were conducted in Salmonella typhimurium and mouse peripheral blood erythrocytes.

2-WEEK STUDIES IN FVB/N MICE

Groups of five male and five female FVB/N mice were dermally administered 0, 7.5, 15, 30, 60, or 120 mg allyl bromide/kg body weight in acetone, 5 days a week for 2 weeks. The survival and mean body weights of all dosed groups of males and females were similar to those of the vehicle controls. There were no increases in the incidences of lesions in dosed mice.

2-WEEK STUDIES IN C57BL/6 MICE

Groups of five male and five female FVB/N mice were administered 0, 7.5, 15, 30, 60, or 120 mg allyl bromide/kg body weight in corn oil by gavage, 5 days a week for 2 weeks. Three 120 mg/kg male mice died prior to the end of the study. Mean body weights of all dosed groups of males and females were similar to those of the vehicle controls. Liver weights of 30 and 60 mg/kg males were significantly greater than those of the vehicle controls. Nonneoplastic lesions of the forestomach, including hyperplasia, inflammation, degeneration, and hyperkeratosis of the forestomach epithelium, were observed in dosed mice.

40-WEEK STUDIES IN FVB/N MICE

Groups of 15 male and 15 female FVB/N mice were administered 0 or 8 mg allyl bromide/kg body weight in corn oil by gavage, 5 days a week for 40 weeks. Survival of dosed mice was similar to that of the vehicle controls. Mean body weights of dosed mice were within 10% of those of the vehicle controls throughout most of the study. There were no chemical-related gross or microscopic findings in dosed mice.

40-WEEK STUDIES IN Tg.AC HEMIZYGOUS MICE

Groups of 15 male and 15 female Tg.AC hemizygous mice were administered 0, 0.5, 1, 2, 4, or 8 mg allyl bromide/kg body weight in corn oil by gavage, 5 days a week for 40 weeks. Survival of dosed mice was similar to that of the vehicle controls. Mean body weights were generally similar between dosed and vehicle control mice throughout the study. In female mice, there were increased numbers of cutaneous and mucocutaneous masses (gross observations) on the body, particularly the vaginal and vulvar area, and these papillomas were observed earlier in the dosed groups. There were positive trends in the incidences of squamous cell papilloma of the vulva and of all skin sites in females.

40-WEEK STUDIES IN C57BL/6 MICE

Groups of 15 male and 15 female C57BL/6 mice were administered 0 or 8 mg allyl bromide/kg body weight in corn oil by gavage, 5 days a week for 40 weeks. Survival of dosed mice was similar to that of the vehicle controls. Mean body weights and organ weights were similar between dosed and vehicle control mice throughout the study. There were no chemical-related gross or microscopic findings in dosed mice.

40-WEEK STUDIES IN p53 HAPLOINSUFFICIENT MICE

Groups of 15 male and 15 female p53 haploinsufficient mice were administered 0, 0.5, 1, 2, 4, or 8 mg allyl bromide/kg body weight in corn oil by gavage, 5 days a week for 40 weeks. Survival of dosed mice was similar to that of the vehicle controls. Mean body weights of dosed mice were within 10% of those of the vehicle controls throughout most of the study. Mean body weights of 8 mg/kg females were 11% to 15% greater than those of the vehicle controls from week 26 to week 33, and those of 4 mg/kg females were generally less after week 21. There were no chemical-related gross or microscopic findings.

GENETIC TOXICOLOGY

Allyl bromide was mutagenic in S. typhimurium strain TA100, with and without exogenous metabolic activation (S9). No mutagenicity was detected in S. typhimurium strain TA98, with or without S9, over the same concentration range tested with TA100. The frequency of micronucleated erythrocytes was assessed in male and female mice for each of the four mouse strains administered allyl bromide by corn oil gavage for 40 weeks. Results in all four studies were concluded to be negative; in addition, no significant changes in the percentages of polychromatic erythrocytes (reticulocytes) among total erythrocytes were observed in any of the four strains of mice.

CONCLUSIONS

Under the conditions of this study, there was no evidence of carcinogenic activity in male or female p53 haploinsufficient mice administered allyl bromide at 0, 0.5, 1, 2, 4, or 8 mg/kg per day by corn oil gavage, 5 days a week for 40 weeks.

There was a marginal increase in the incidence of squamous cell papillomas, primarily of the vulva, in female Tg.AC mice administered allyl bromide by corn oil gavage for 40 weeks. No treatment-related neoplasms were seen in male Tg.AC hemizygous mice administered allyl bromide by gavage at 0.5, 1, 2, 4, or 8 mg/kg, 5 days per week for 40 weeks.
 

Synonyms: AB; 3-bromopropene; 3-bromopropylene; propene; 3-bromo-; 2-propenyl bromide 


Summary of the 40-Week Gavage and Genetic Toxicology Studies of Allyl Bromide in FVB/N Mice
  Male Female
Concentrations in
corn oil
0 or 8 mg/kg 0 or 8 mg/kg
Body weights Dosed group similar to the vehicle control group Dosed group similar to the vehicle control group
Survival rates 15/15, 14/15 15/15, 14/15
Nonneoplastic effects None None
Neoplastic effects None None
Genetic toxicology
Salmonella typhimurium gene mutations: Positive with and without S9 in TA100; negative with and without S9 in TA98
Micronucleated erythrocytes
Mouse peripheral blood in vivo:

Negative in males and females



Summary of the 40-Week Gavage and Genetic Toxicology Studies of Allyl Bromide in Tg.AC Hemizygous Mice
  Male Female
Concentrations in
corn oil
0, 0.5, 1, 2, 4, or 8 mg/kg 0, 0.5, 1, 2, 4, or 8 mg/kg
Body weights Dosed groups similar to the vehicle control group Dosed groups similar to the vehicle control group
Survival rates 12/15, 9/15, 9/15, 12/15, 6/15, 11/15 9/15, 10/15, 8/15, 8/15, 11/15, 12/15
Nonneoplastic effects None None
Neoplastic effects None Skin, vulva: squamous cell papilloma (2/15, 4/15, 1/15, 6/15, 5/14, 7/15)
Skin, all sites: squamous cell papilloma (4/15, 6/15, 3/15, 7/15, 8/14, 9/15)
Genetic toxicology
Salmonella typhimurium gene mutations: Positive with and without S9 in TA100; negative with and without S9 in TA98
Micronucleated erythrocytes
Mouse peripheral blood in vivo:

Negative in males and females



Summary of the 40-Week Gavage and Genetic Toxicology Studies of Allyl Bromide in C57BL/6 Mice
  Male Female
Concentrations in
corn oil
0 or 8 mg/kg 0 or 8 mg/kg
Body weights Dosed group similar to the vehicle control group Dosed group similar to the vehicle control group
Survival rates 14/15, 15/15 15/15, 12/15
Nonneoplastic effects None None
Neoplastic effects None None
Genetic toxicology
Salmonella typhimurium gene mutations: Positive with and without S9 in TA100; negative with and without S9 in TA98
Micronucleated erythrocytes
Mouse peripheral blood in vivo:

Negative in males and females



Summary of the 40-Week Gavage and Genetic Toxicology Studies of Allyl Bromide in p53 Haploinsufficient Mice
  Male Female
Concentrations in
corn oil
0, 0.5, 1, 2, 4, or 8 mg/kg 0, 0.5, 1, 2, 4, or 8 mg/kg
Body weights 0.5, 4, and 8 mg/kg groups greater (generally within 10%) than the vehicle control group 8 mg/kg group greater (generally within 10%) than the vehicle control group; 4 mg/kg group less (generally within 10%) than the vehicle control group
Survival rates 15/15, 14/15, 15/15, 15/15, 13/15, 15/15 13/15, 14/15, 13/15, 14/15, 15/15, 13/15
Nonneoplastic effects None None
Neoplastic effects None None
Level of evidence of carcinogenic activity No evidence No evidence
Genetic toxicology
Salmonella typhimurium gene mutations: Positive with and without S9 in TA100; negative with and without S9 in TA98
Micronucleated erythrocytes
Mouse peripheral blood in vivo:

Negative in males and females


Report Date: April 2008

Pathology Tables, Survival and Growth Curves from NTP GMM Studies

Target Organs & Incidences from GMM Studies

You may link to the full study report in PDF format. If you have difficulty accessing the document, please send email to the NTP Webmaster [ Send Email ] and identify documents/pages for which access is required. (Note: A print ready copy of the document is presented in Portable Document Format (PDF))
 

NTP is located at the National Institute of Environmental Health Sciences, part of the National Institutes of Health.